BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15764889)

  • 1. Discordant response to chemotherapy between lymphadenopathy and bone lesions on gallium-67 scanning in Hodgkin's disease.
    Bazarjani S; Di Primio G
    Clin Nucl Med; 2005 Apr; 30(4):271-3. PubMed ID: 15764889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
    Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
    Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
    Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
    Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gallium-67 citrate and technetium-99m tetrofosmin scan to detect Hodgkin's disease.
    Liu FY; Shiau YC; Yen RF; Wang JJ; Ho ST; Kao CH
    Ann Nucl Med; 2003 Sep; 17(6):439-42. PubMed ID: 14575376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can 67Ga citrate predict the efficacy of chemotherapy early in Hodgkin's lymphoma?].
    Delgado M; Razola P; Abós MD; Martí JL; Murillo L; García F; Prats E; Banzo J
    Rev Esp Med Nucl; 2001 Feb; 20(1):40-1. PubMed ID: 11181330
    [No Abstract]   [Full Text] [Related]  

  • 6. Hodgkin's disease. Prognostic value of Gallium-67 scintigraphy.
    Hervás I; Segura A; López-Tendero P; Bello P; González-Cabezas P; Flores D; Yuste A; Pérez-Velasco R; Girones R; Mateo A
    Q J Nucl Med; 2003 Jun; 47(2):101-8. PubMed ID: 12865870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misleading Ga-67 uptake in a patient with Hodgkin's disease, mediastinal deviation, and pulmonary compression.
    Stark P; Steinmetz A; Hefetz M; Hardoff R
    Clin Nucl Med; 2002 Dec; 27(12):898-9. PubMed ID: 12607876
    [No Abstract]   [Full Text] [Related]  

  • 8. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
    Burns DE; Schiffman FJ
    Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ga-67-avid massive cellulitis within a chronic lymphedematous limb in a survivor of Hodgkin's disease.
    Suga K; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
    Clin Nucl Med; 2001 Sep; 26(9):791-2. PubMed ID: 11507304
    [No Abstract]   [Full Text] [Related]  

  • 10. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
    Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
    Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
    Ha CS; Choe JG; Kong JS; Allen PK; Oh YK; Cox JD; Edmund E
    Cancer; 2000 Sep; 89(6):1371-9. PubMed ID: 11002233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of Ga-67 citrate uptake in the left neck mass of Hodgkin's disease and reversion of double scoliosis of cervical-thoracic and lower lumbar vertebrae.
    Zwick M; Shih WJ; Greenwood M; Cibull ML; Miller S
    Ann Nucl Med; 2000 Aug; 14(4):299-301. PubMed ID: 11023031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aseptic necrosis. A scintigraphic imitator of osseous involvement in Ga-67 avid lymphoma.
    Van de Wiele C; Dierckx RA; Noens L; Simons M
    Clin Nucl Med; 1997 Feb; 22(2):101-3. PubMed ID: 9031767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone lymphoma. Comparison of Tl-201 and Ga-67 citrate scintigraphy in assessment of treatment response.
    Roach PJ; Janicek MJ; Kaplan WD
    Clin Nucl Med; 1996 Sep; 21(9):689-94. PubMed ID: 8879868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyostotic fibrous dysplasia as a mimic of bony metastatic disease.
    Jones DN; Marion M
    Clin Nucl Med; 1991 Jan; 16(1):55-7. PubMed ID: 1999061
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemibody uptake on bone scintigraphy in polyostotic fibrous dysplasia.
    Rudenko B; Klingelschmitt S; Aubry S; Bamba M; Boulahdour H
    Clin Nucl Med; 2003 Dec; 28(12):992-3. PubMed ID: 14663327
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent lymphoma detected on F-18 FDG coincidence imaging with negative findings on Ga-67 citrate scintigraphy.
    Ojha B; Bender LW; Francisco R; Scott JW
    Clin Nucl Med; 2002 Sep; 27(9):638-40. PubMed ID: 12192281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serial quantitative gallium-67 tumor uptake in assessing response rates for chemotherapy in lymphoma patients.
    Ballani NS; Khan HA; Al-Mohannadi SH; Al-Huda FA; Usmani S; Tuli MM; Al-Shemmari SH; Al-Sawagh HF; Al-Enezi FH
    Nucl Med Commun; 2008 Jun; 29(6):527-34. PubMed ID: 18458599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET-positive polyostotic fibrous dysplasia mimicking Ollier disease.
    Nishio J; Kuwabara Y; Nabeshima S; Iwasaki H; Naito M
    In Vivo; 2013; 27(6):821-6. PubMed ID: 24292588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.